These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7912326)

  • 41. Endometrial surveillance in tamoxifen users: role, timing and accuracy of hysteroscopic investigation: observational longitudinal cohort study.
    Saccardi C; Gizzo S; Patrelli TS; Ancona E; Anis O; Di Gangi S; Vacilotto A; D'Antona D; Nardelli GB
    Endocr Relat Cancer; 2013 Aug; 20(4):455-62. PubMed ID: 23629476
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen.
    Lahti E; Blanco G; Kauppila A; Apaja-Sarkkinen M; Taskinen PJ; Laatikainen T
    Obstet Gynecol; 1993 May; 81(5 ( Pt 1)):660-4. PubMed ID: 8469450
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gynaecological monitoring during tamoxifen therapy.
    Oladipo A
    Lancet; 1995 Jan; 345(8944):254. PubMed ID: 7823731
    [No Abstract]   [Full Text] [Related]  

  • 44. [Changes in the endometrium in treatment of breast carcinoma with tamoxifen].
    Reslová T; Tosner J; Vávrová I; Resl M
    Ceska Gynekol; 1997 Oct; 62(5):277-9. PubMed ID: 9600168
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endometrial effects of exemestane compared to tamoxifen within the Tamoxifen Exemestane Adjuvant Multicenter (TEAM) trial: results of a prospective gynecological ultrasound substudy.
    Kieback DG; Harbeck N; Bauer W; Hadji P; Weyer G; Menschik T; Hasenburg A
    Gynecol Oncol; 2010 Dec; 119(3):500-5. PubMed ID: 20832103
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Morphologic endometrium changes with tamoxifen].
    Dallenbach-Hellweg G; Hahn U; Schmidt D
    Zentralbl Gynakol; 1996; 118(6):365-9. PubMed ID: 8768015
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnostic pitfalls of ultrasonographic uterine screening in women treated with tamoxifen.
    Bornstein J; Auslender R; Pascal B; Gutterman E; Isakov D; Abramovici H
    J Reprod Med; 1994 Sep; 39(9):674-8. PubMed ID: 7807477
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Endometrial thickening in postmenopausal breast cancer patients taking tamoxifen: a cross-sectional study.
    Sinawat S; Chiyabutra T
    J Med Assoc Thai; 2004 Oct; 87 Suppl 3():S59-63. PubMed ID: 21218592
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Different coexisting endometrial histological features in asymptomatic postmenopausal breast cancer patients treated with tamoxifen.
    Cohen I; Altaras MM; Shapira J; Tepper R; Cordoba M; Figer A; Zalel Y; Dror Y; Beyth Y
    Gynecol Obstet Invest; 1997; 43(1):60-3. PubMed ID: 9015703
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Investigation of endometrial abnormalities in asymptomatic women treated with tamoxifen and an evaluation of the role of endometrial screening.
    Love CD; Muir BB; Scrimgeour JB; Leonard RC; Dillon P; Dixon JM
    J Clin Oncol; 1999 Jul; 17(7):2050-4. PubMed ID: 10561257
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Secretory endometrial adenocarcinoma in a patient on tamoxifen for breast cancer: a report of a case.
    Folk JJ; Mazur MT; Eddy GL; Musa AG
    Gynecol Oncol; 1995 Jul; 58(1):133-5. PubMed ID: 7789881
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of adjuvant tamoxifen on the endometrium in women with breast cancer: a prospective study using office endometrial biopsy.
    Barakat RR; Gilewski TA; Almadrones L; Saigo PE; Venkatraman E; Hudis C; Hoskins WJ
    J Clin Oncol; 2000 Oct; 18(20):3459-63. PubMed ID: 11032585
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Baseline endometrial assessment before tamoxifen for breast cancer in asymptomatic menopausal women.
    Garuti G; Cellani F; Centinaio G; Sita G; Nalli G; Luerti M
    Gynecol Oncol; 2005 Jul; 98(1):63-7. PubMed ID: 15894357
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The use of transvaginal ultrasound and saline infusion sonohysterography for the evaluation of asymptomatic postmenopausal breast cancer patients on tamoxifen.
    Schwartz LB; Snyder J; Horan C; Porges RF; Nachtigall LE; Goldstein SR
    Ultrasound Obstet Gynecol; 1998 Jan; 11(1):48-53. PubMed ID: 9511196
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Primary multiple neoplasm of the endometrium and adjuvant hormone therapy in patients with breast cancer].
    Bakhidze EV; Maksimov SIa; Barash NIu; Berstein LM; Semiglazov VF; Sheĭko EV; Novik VI
    Vopr Onkol; 1998; 44(2):170-4. PubMed ID: 9615821
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endometrial thickness and ovarian cysts as measured by ultrasound in asymptomatic postmenopausal breast cancer patients on various adjuvant treatments including tamoxifen.
    Lindahl B; Andolf E; Ingvar C; Liedman R; Ranstam J; Willén R
    Anticancer Res; 1997; 17(5B):3821-4. PubMed ID: 9427787
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Asymptomatic carcinoma of the endometrium in a patient on adjunctive tamoxifen therapy for carcinoma of the breast.
    O'Neill E; Rodríguez Mojica W
    Bol Asoc Med P R; 1992 Feb; 84(2):74-7. PubMed ID: 1388459
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hysteroscopic dynamic assessment of the endometrium in patients treated with long-term tamoxifen.
    Pérez-Medina T; Salazar FJ; San-Frutos L; Ríos M; Jiménez JS; Troyano J; Cayuela E; Iglesias E
    J Minim Invasive Gynecol; 2011; 18(3):349-54. PubMed ID: 21411378
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Adverse effects of tamoxifen on the female genital tract].
    Anteby E; Yagel S; Zacut D; Palti Z; Hochner-Celnikier D
    Harefuah; 1993 Nov; 125(9):267-70, 327. PubMed ID: 8253418
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Endometrial changes with chronic tamoxifen use.
    Loret de Mola JR
    Curr Opin Obstet Gynecol; 1997 Jun; 9(3):160-4. PubMed ID: 9263698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.